Advanced Enzyme Technologies Limited Cash Flow Conversion Efficiency
Advanced Enzyme Technologies Limited cash flow conversion efficiency. Based on the latest financial reports, Advanced Enzyme Technologies Limited (ADVENZYMES) has a cash flow conversion efficiency ratio of 0.042x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs647.13 Million ≈ $7.00 Million USD) by net assets (Rs15.34 Billion ≈ $165.85 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Advanced Enzyme Technologies Limited (2008–2026)
Cash flow conversion efficiency of Advanced Enzyme Technologies Limited from 2008 to 2026. This chart illustrates how Advanced Enzyme Technologies Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View ADVENZYMES live share price for real-time trading data and today's change.
Advanced Enzyme Technologies Limited Cash Flow Conversion Ratio Explained
Advanced Enzyme Technologies Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Advanced Enzyme Technologies Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Advanced Enzyme Technologies Limited ranked by their cash flow conversion efficiency. Also see Advanced Enzyme Technologies Limited market cap and net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hefei Kewell Power System Co Ltd
SHG:688551
|
0.001x |
|
TWFG, Inc. Class A Common Stock
NASDAQ:TWFG
|
0.034x |
|
Hangzhou Prevail Optoelectronic Equipment Co Ltd
SHE:300710
|
0.023x |
|
Chen Ke Ming Food Manufacturing Co Ltd
SHE:002661
|
0.084x |
|
Hangzhou Yitong New Material Co. LTD
SHE:300930
|
-0.024x |
|
MCNEX Co. Ltd
KQ:097520
|
0.085x |
|
Cartesian Growth Corporation III Class A Ordinary Shares
NASDAQ:CGCT
|
-0.001x |
|
Sidetrade
PA:ALBFR
|
0.086x |
Annual Cash Flow Conversion Efficiency for Advanced Enzyme Technologies Limited (2008–2026)
The table below shows the annual cash flow conversion efficiency of Advanced Enzyme Technologies Limited from 2008 to 2026. Review Advanced Enzyme Technologies Limited free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs16.83 Billion ≈ $182.02 Million |
Rs1.73 Billion ≈ $18.66 Million |
0.103x | +0.99% |
| 2025-03-31 | Rs14.69 Billion ≈ $158.83 Million |
Rs1.49 Billion ≈ $16.12 Million |
0.102x | -1.54% |
| 2024-03-31 | Rs13.71 Billion ≈ $148.28 Million |
Rs1.41 Billion ≈ $15.29 Million |
0.103x | -5.67% |
| 2023-03-31 | Rs12.84 Billion ≈ $138.88 Million |
Rs1.40 Billion ≈ $15.18 Million |
0.109x | +1.93% |
| 2022-03-31 | Rs11.40 Billion ≈ $123.33 Million |
Rs1.22 Billion ≈ $13.23 Million |
0.107x | -32.14% |
| 2021-03-31 | Rs10.31 Billion ≈ $111.47 Million |
Rs1.63 Billion ≈ $17.62 Million |
0.158x | -2.71% |
| 2020-03-31 | Rs8.67 Billion ≈ $93.81 Million |
Rs1.41 Billion ≈ $15.24 Million |
0.162x | -10.95% |
| 2019-03-31 | Rs7.05 Billion ≈ $76.22 Million |
Rs1.29 Billion ≈ $13.90 Million |
0.182x | -8.51% |
| 2018-03-31 | Rs5.82 Billion ≈ $62.91 Million |
Rs1.16 Billion ≈ $12.54 Million |
0.199x | -12.24% |
| 2017-03-31 | Rs4.73 Billion ≈ $51.10 Million |
Rs1.07 Billion ≈ $11.61 Million |
0.227x | -34.12% |
| 2016-03-31 | Rs2.83 Billion ≈ $30.65 Million |
Rs977.51 Million ≈ $10.57 Million |
0.345x | +38.92% |
| 2015-03-31 | Rs2.16 Billion ≈ $23.41 Million |
Rs537.31 Million ≈ $5.81 Million |
0.248x | -23.58% |
| 2014-03-31 | Rs1.71 Billion ≈ $18.50 Million |
Rs555.67 Million ≈ $6.01 Million |
0.325x | +31.07% |
| 2013-03-31 | Rs1.66 Billion ≈ $17.94 Million |
Rs411.24 Million ≈ $4.45 Million |
0.248x | -73.06% |
| 2012-03-31 | Rs984.09 Million ≈ $10.64 Million |
Rs905.46 Million ≈ $9.79 Million |
0.920x | +4950.18% |
| 2011-03-31 | Rs645.35 Million ≈ $6.98 Million |
Rs11.76 Million ≈ $127.15K |
0.018x | -91.07% |
| 2010-03-31 | Rs489.29 Million ≈ $5.29 Million |
Rs99.82 Million ≈ $1.08 Million |
0.204x | -30.61% |
| 2009-03-31 | Rs379.81 Million ≈ $4.11 Million |
Rs111.66 Million ≈ $1.21 Million |
0.294x | +56.82% |
| 2008-03-31 | Rs319.19 Million ≈ $3.45 Million |
Rs59.84 Million ≈ $647.15K |
0.187x | -- |
About Advanced Enzyme Technologies Limited
Advanced Enzyme Technologies Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of enzymes and probiotics in India, Europe, the United States, Asia, and internationally. The company offers serratiopeptidase, fungal lactase, peptizyme SP, nattokinase, fungal lipase, alpha galactosidase, saccharomyces boulardii, hemicellulose, papain, bromelain… Read more